| Overview |
| bsm-90230r-50µL |
| EIF2AK4 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human GCN2 |
| 1-59/1649 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 440275 |
| Q9P2K8 |
| EIF2AK4; Eukaryotic Translation Initiation Factor 2 Alpha Kinase 4; GCN2; KIAA1338; EIF-2-Alpha Kinase GCN2; GCN2-Like Protein; Eukaryotic Translation Initiation Factor 2-Alpha Kinase 4; General Control Nonderepressible; GCN2 EIF2alpha Kinase; EIF-2-Alpha Kinase; EC 2.7.11.1; PVOD2 |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |